NCT02325206View on ClinicalTrials.gov

Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Type 1 Diabetes

Interventions

DRUG

dapagliflozin

one administration in the morning

DRUG

Placebo

one administration in the morning

Trial Locations (1)

30173

Kinder - und Jugendkrankenhaus AUF DER BULT, Hanover

All Listed Sponsors

lead

Kinderkrankenhaus auf der Bult

OTHER

NCT02325206 - Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter